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Summary 
Young adult Lewis rats were maintained on diets containing 0.015 or 0.027% cyclosporin A 
(CSA) for periods of up to 6 wk. All animals showed complete depletion of medullary thymocytes 
(CD4+8 -  and CD4-8 + , T cell receptor [TCR] ct/~  ~, Thy-1  m~~  terminal deoxynucleotidyl 
transferase negative [TdT-]) and a 50% reduction in the number of TdT- cortical thymocytes 
(CD4+8 +, TCR c~/~  l~  Thy-1  m~d) within 1 wk of CSA treatment. In addition, about half 
of the animals displayed a 50% reduction in the number ofTdT + cortical thymocytes (CD4+8 +  , 
TCIL odB  l~  Thy-lhi). These intrathymic changes were accompanied by a reciprocal increase 
in the number of double-positive (DP; CD4+8 +) T ceils in lymph nodes (LN) and spleens. To 
confirm that the latter T ceils were recent thymic emigrants (RTE), CSA-treated rats were injected 
intrathymically with fluorescein isothiocyanate, and the phenotype of the labeled T cells appearing 
in LN was determined 16 h later. The results demonstrated that, in addition to those RTE exported 
in normal animals (>90% medullary origin), the emigration of DP thymocytes, including large 
numbers of TdT + thymocytes, was markedly increased.  The presence  of TdT + cells, which 
normally do not leave the thymus, clearly identifies the DP RTE as originating from the thymus 
cortex. Intrathymic labeling studies also directly demonstrated that export of all thymocyte subsets 
ceases within 9 d of CSA treatment; and thymectomy experiments confirmed that the CSA- 
induced increase in phenotypically immature T cells resulted primarily from the disturbance of 
thymocyte maturation and emigration, rather than from a direct effect on preexisting T  cells. 
These results suggest that a wave of cortical thymocytes, many of which presumably have not 
yet undergone negative selection, is released  from the thymus during the first week of CSA treatment. 
The presence of these potentially unselected cells in peripheral lymphoid tissues may help to 
explain  the increased frequency of autoreactive T  cells observed in CSA-treated animals. 
C 
Yclosporin A  (CSA) 1 is a product of fungal metabo- 
lism that has very useful immunosuppressive proper- 
ties clinically in the prevention of organ graft rejection and 
GVHD,  and  in  the  treatment  of autoimmune disorders 
(reviewed in references 1 and 2). However, under certain cir- 
cumstances CSA has the paradoxical effect of promoting syn- 
geneic GVHD and organ-specific autoimmunity. Thus, CSA 
treatment after irradiation and syngeneic bone marrow trans- 
plantation produces severe GVHD in rats (3-7) and milder 
GVHD in several strains of mice (8). In addition, CSA treat- 
ment of neonatal rodents leads to organ-specific autoimmune 
disease (9, 10). The role of CSA in these models appears to 
be multifold: i.e., arrest of thymocytopoiesis at the double- 
Abbreviations used in this ~per: CSA, cyclosporin A; DP, double positive; 
RTE, recent thymic emigrants; SPL, spleen; TdT, terminal deoxynucleotidyl 
transferase. 
positive (DP;  CD4+8 +)  stage  (11-13); interference with 
positive and negative intrathymic selection (14-16), possibly 
secondary to selective inhibition of cytokine production (17, 
18) and/or damage to stromal cells (19-25);  and inhibition 
of regulatory T cell maturation (13). The net effect of these 
actions is to skew the T cell repertoire towards unregulated 
effector T  cells bearing self-reactive TCRs. However, little 
is known about the origin, phenotype(s), and fate of these 
autoreactive T  cells. 
It has been widely reported that long-term CSA treatment 
in  mice  leads  to  the  accumulation  of  double-negative 
(CD4-8-) T cells in the peripheral lymphoid tissues, some 
of which may be T cells that have escaped negative intrathymic 
selection  (11, 13,  19). In contrast, we (26,  27) and others 
(8, 28) have recently reported that short-term CSA treatment 
of young adult rats results in the appearance in LN of large 
numbers of double-positive T  cells. In addition, we have 
demonstrated that most of these cells are very small and have 
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ferase-positive (TdT +) phenotype (26, 27). This phenotype 
and size  profile are normally expressed only by cortical thymo- 
cytes (29),  thereby suggesting that these DP LN T cells are 
recent emigrants from the thymus cortex. 
In the present study, the kinetics of appearance of DP T 
cells is defined during a short-term course of CSA treatment, 
and their intrathymic origin is traced by direct intrathymic 
labeling with FITC. The results demonstrate that >95% of 
medullary thymocytes and, in half of the animals,  ~50% of 
TdT + cortical thymocytes emigrate to the peripheral lym- 
phoid tissues during the first week of CSA treatment, after 
which export of thymocytes ceases. The implications for au- 
toimmunity of the release of a wave of potentially unselected 
cortical thymocytes to the periphery is discussed. 
immunofluorescence samples were analyzed using the FACScan  | 
Research Software (Becton Dickinson & Co.). Dead cells, erythro- 
cytes, and myeloid  cells were excluded on the basis of forward and 
side scatter. Immunofluorescent staining for intranuclear TdT was 
performed as described (27) and examined by fluorescence mi- 
croscopy. 
lntrathymic Labeling of Thymocytes with FITC.  Rats  were injected 
intrathymically with FITC (20 #1 of 1 mg/ml FITC per lobe) as 
described (37). Animals were killed at various intervals after the 
intrathymic injection, and LN, SPL, and thymus were harvested. 
Single-cell suspensions  were made and examined  for surface  antigens 
by flow immunocytometry.  Suffident data (2,000-5,000 events) was 
obtained by live gating to permit detailed analysis of the minor 
subset of FITC + cells (0.1-1.0%). Data for total lymphocytes  were 
acquired on the same sample with the FITC gate off to minimize 
variations in fluorescence  staining between recent thymic emigrants 
(RTE) and total cells. 
Materials  and Methods 
CSA  Treatment of Rats.  4-6-wk-old female inbred Lewis rats, 
bred and housed in our animal care facility,  were used in this study. 
CSA (provided  by Sandoz  Inc., East Hanover, NJ) was administered, 
via the oral route, in their food. Powdered CSA was mixed into 
standard rat chow in lieu of sucrose at a concentration of 0.015 
or 0.027% and pelleted (Dyets, Inc., Bethlehem, PA) (30). Rats 
were maintained ad libitum on either the CSA-containing food, 
or on the same food lacking CSA, for 1-42 d. Previous studies 
have demonstrated that this protocol establishes mean serum levels 
of CSA equivalent to that accomplished  by parenteral administra- 
tion of a therapeutic dose (15 mg/kg body weight/d)  (19). 
Cells.  LN were procured either by biopsy from the cervical and 
inguinal areas or at necropsy from cervical, axillary, brachial, and 
inguinal areas. To prevent disruption of the thymus and its cross- 
contamination of peripheral lymphoid tissues, animals were killed 
with an overdose  of  ether (rather than by cervical  dislocation) until 
all cardiac activity ceased, and the thymus was harvested after LN 
and spleen (SPL). Single-ceU suspensions ofLN, SPL, and thymus 
were made by pressing tissues through stainless steel tissue sieves 
into cold RPMI. 
Antibodies.  The following mouse mAbs were purchased from 
Bioproducts for Science (Indianapolis, IN); OX8 (anti-CD8) (31), 
W3/25 (anti-CD4) (31), tL73 (directed against a constant deter- 
minant of  rat TCP, or/B) (32), OX22 (anti-high molecular weight 
CD45RC) (33), and OX7 (anti-Thy-l.1)  (34). The rat mAb DS4.23 
(anti-RT6.1) (35) was kindly provided  by Dr. D.L. Greiner (Depart- 
ment of Pathology,  University  of Connecticut Health Center). Most 
of these mAbs were obtained as either FITC, PE, or biotin con- 
jugates. When the conjugated form was not available, the anti- 
bodies were conjugated with FITC or biotin  according to the 
method of Goding (36). Red 613-conjugated streptavidin (tandem 
conjugate of PE and Texas red) was purchased from GIBCO BRL 
(Gaithersburg, MD). FITC-conjugated goat anti-rat IgG H  + L 
chains (mouse serum absorbed) and goat anti-mouse IgG H  + L 
chains (rat serum absorbed) were obtained from Caltag Laborato- 
ries (San Francisco, CA). Affinity-purified F(ab')2 rabbit IgG an- 
tibody to homogeneous calf TdT was obtained from Supertechs, 
Inc. (Bethesda, MD). 
Immunofluorescence.  Direct and indirect immunofluorescence 
assays for surface antigens on lymphoid cells were performed as 
described (37). Cells were processed on a FACScan  |  flow cytom- 
eter (Becton Dickinson & Co., Mountain View, CA) equipped with 
an argon ion laser (488 nm); and data from two- to three-color 
Results 
K~net~s ff Appearan~e q/'DP T Cells ~n LN ~ CSA-treated 
Rats.  Consistent with our previous reports (26, 27), a dra- 
matic increase in the percentage of DP T cells in the periph- 
eral lymphoid tissues occurred in *50% of CSA-treated rats, 
whereas the remaining CSA-treated rats showed only a slight 
increase in DP T cells. When present in large numbers, the 
DP cells were detected by day 3 of CSA treatment and in- 
creased progressively to reach peak levels of up to 70% by 
day 7 (Fig.  1).  This increase in DP T  cells was associated 
with a four- to sixfold decrease  in the percentage of DN 
(CD4-8-)  B cells and a two- to threefold decrease in the 
percentage of SP (CD4 +  8- and CD4- 8 +) T cells. Inasmuch 
as the absolute number of B cells in SPL remained constant, 
these results indicated that the total number of T  cells was 
increased by approximately twofold in these rats,  primarily 
by the accumulation of DP T  cells. 
Further phenotypic analysis (Fig. 2) showed that the small 
size and TCR o~//~  l~  Thy-1  hi/m~ fluorescence profiles of the 
DP T cells in LN of CSA-treated rats were almost identical 
to those of immature cortical thymocytes; and that most of 
the DP T  cells were TdT + (data not shown). This analysis 
also showed that CSA treatment resulted in loss of medium 
size, Thy-1  l~  TCR O//~ hi, TdT-  T  cells within 7 d. We 
have previously shown (37) that such T  cells have a single- 
positive,  RT6-,  CD45RC-  phenotype  characteristic  of 
RTE  from  the  thymus  medulla  and  their  immediate 
descendants. 
Additional evidence that the DP T  cells that appeared  in 
LN of CSA-treated rats were RTE was found in the inverse 
correlation between the mean percentage of DP T  ceils in 
LN of groups of rats (Fig.  3 A) and the mean number of 
thymocytes in these same animals (Fig.  3 B) as a function 
of time. Indeed, as shown in Table 1, those rats that had <700 
x  106 (mean, 568  x  106) thymocytes 3-7 d after CSA treat- 
ment also had a significantly higher mean percentage of DP, 
Thy-1  hi, TCR et/B l~  LN T  cells than did those that had 
>700  x  106  (mean,  947  x  106) thymocytes (p  <0.001). 
This correlation suggests that the animals with the smallest 
thymi were those that had cumulatively exported the largest 
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numbers of cortical thymocytes to the periphery during the 
first  week of CSA treatment. 
To confirm the role of the thymus in maintaining the pool 
of Thy-1 + T cells in peripheral lymphoid tissues, LN biop- 
sies were obtained at time intervals from thymectomized rats 
that had been maintained on CSA or control lab chow for 
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Figure  1.  Two-color gated flow 
cytometric analysis of the expression 
of CD8 and/or CD4 by LN cells 
from 0.027% CSA-treated and con- 
trol rats, as compared with normal 
thymocytes. 
up to 32 d. The results in Table 2 show that thymectomy, 
but not sham-thymectomy, led to the loss of Thy-1 + T cells 
from LN within i wk, presumably by permitting their matu- 
ration to Thy-1- T cells while preventing their replacement 
by RTE (37).  The results also demonstrate that the treat- 
ment of rats with CSA either 10 d after or the same day as 
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Figure  2.  Gated flow cytometric analysis of TCR o~/B and Thy-1 expression vs. forward  light scatter (relative cell size) by LN cells from 0.027% 
CSA-treated and control rats. The corresponding  profiles of normal thymocytes  are included  for comparison.  The windows demarcate  two subsets 
of TCR a//3 + cells: the upper  window being medium sized, TCR <x/Bhi; the lower being small, TCR a/Blow.  The windows also demarcate  two 
subsets of Thy-1 + cells: the upper being mostly small Thy-lhi/m~; and the lower being medium-sized Thy-P  ~  The percentage of total LN cells within 
each window is indicated. 
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Figure  3.  Kinetics of (.4) increase of DP (CD4+8 +) T cells in LN and 
(/3) decrease of total cells in thymus of 0.027% CSA-treated rats. Results 
in A represent mean percent of total LN cells that are DP at the indicated 
times during CSA treatment (four animals per point), and are presented 
as the line of  best fit for all points as determined by linear regression anal- 
ysis: r  2 =  0.99; slope =  4.85. Results in B for days 0-7 depict mean _+ 
SD of total thymocytes from four individual rats, and those for days 14 
and 21 represent the averaged values from four pooled thymi. 
Table  2.  Effects of Thymectomy  and~or CSA  Treatment 
on  Thy-1 + T  Cells in LN 
Percent of LN T  cells expressing Thy-1 after  treatment 
Day  Sham-Thymectomy  Thymectomy  Thymectomy +  CSA 
7  21.6  +_  2.6  1.1  +_  0.3  1.6  +  0.8 
17  22.4  +-  0.6  1.4  +-  0.6  1.7  _+  0.5 
32  17.4  +_  0.7  2.9  _+  0.4  3.6  +-  1.1 
5-8-wk-old Lewis rats were thymectomized  or sham-thymectomized  10 d 
before initiation of CSA therapy and maintained on a 0.027% CSA or 
control diet for 32 d. LN cells were obtained through biopsies of cervical 
or inguinal LN at the indicated intervals, stained with mAbs to TCR 
oUfl and Thy-l.1 antigens, and analyzed by flow cytometry. Results 
represent mean _+ SD of three to six rats. 
(data not shown) thymectomy neither pgevents the disappear- 
ance nor causes the reappearance of Thy-1 ÷ T  cells in LN. 
Hence, the qualitative and quantitative effects of CSA treat- 
ment on subpopulations  of LN T  cells appear to result al- 
most exclusively from its effects on the intrathymic develop- 
ment, export, and/or immediate postthymic survival of RTE. 
Direct Analysis of  RTE in CSA-treated Rats.  The intrathymic 
FITC labeling technique was used to directly document thymic 
export and to examine the phenotypic characteristics of RTE 
during CSA treatment.  RTE were defined as FITC ÷ T  cells 
identified in LN 16 h after intrathymic labeling. The results 
demonstrate that the RTE in CSA-treated rats differed quan- 
titatively and qualitatively from their counterparts in normal 
rats.  Thus, as shown in Fig. 4, the number of cells released 
from the thymus  of these rats  per unit  time was  approxi- 
mately twofold above control levels by day 3 of CSA treat- 
ment, decreased to below control levels by day 5, and ceased 
entirely by day 9. The changes in the rate of thymic export 
on each of these days differed significantly (p <0.05)  from 
control values  at  time 0. 
The results in Fig. 5 show that the increase in thymic ex- 
Table  1.  Distribution Analysis  of the Percentage of CD4+8 +,  Thy-1 h;,  TCR  ot/fl t°~ LN Cells as a Function of the Number of 
Thymocytes Present in Rats  Treated with  0.027%  CSA for 3-7 d 
No.  of thymocytes  Percent  positive LN cells (mean  _+  SD) 
Range  Mean  +_  SD  CD4+8 ÷  Thy-1  hi  TCR a/fl l°'' 
x lO -6 
459-698  568  _+  203  27.6+_  21.6"  33.5  +_  25.2*  27.8  +  20.4* 
788-1,125  947  _+  140  4.0  _+  3.4  2.14  +-  3.3  5.2  +-  19 
*/, <0.001. 
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Figure 4.  The percentage (mean _+ SD) of RTE in LN of normal rats 
and those treated with 0.015% CSA for 3-9 d. All rats were injected in- 
trathymically with FITC 16 h before death. FITC + T cells (RTE) were 
identified by simultaneous flow cytometric analysis for FITC and TCR 
c~/fl § cells. The proportion of FITC § LN cells was significantly greater 
than normal after 3 d of CSA therapy (p < 0.05) and significantly lower 
on days 5 (p < 0.02) and 9 (p <  0.001). 
port in CSA-treated rats was due almost entirely to a five- 
and eightfold increase in the release of DP and TCR odfl  l~ 
thymocytes, respectively, the difference between these values 
presumably  being  the  enhanced  export  of  the  CD4-8 + 
precursors of CD4+8 + cortical thymocytes. Thus,  in addi- 
tion to the continued release of the CD4 § 8-  and CD4- 8 § 
subsets of Thy-1  med/l~  TCR  O//fi hi medullary  thymocytes 
through day 5 in CSA-treated animals, there was a threefold 
increase (4.3 to 11.8%) in the release of the Thy-1 mea subset 
of DP,  TCR odfi l~  cortical thymocytes on day 3,  and the 
appearance of two new subsets (CD4+8 + and CD4  8 +) of 
Thy-1  hi,  TCR  odfl l~  T  cells,  which  were  not  readily  de- 
tectable  in  control  rats.  Unlike  the  cells  in  the  Thy-1  inCa 
subset  of DP  RTE,  the  cells  in  the  Thyl hi  subsets  were 
TdT +  (data  not  shown).  This  clearly  indicated  that  they 
originated  from the  thymus cortex  (38,  39).  In aggregate, 
the Thy-1  reed and Thy-1  hi subsets ofDP, TCR o~/t3  l~  T  cells 
accounted  for ~40%  of the total RTE in CSA-treated rats 
on day 3, whereas such cells accounted for *5%  of total  RTE 
in control rats (37).  In the experiment in Fig.  5,  export of 
both of the TdT +  and TdT-  subsets of DP RTE from the 
thymus cortex decreased markedly between days 3 and 5 of 
CSA treatment, whereas export of SP RTE from the medulla 
continued through day 5. However, in other experiments in 
which individual time points were tested, emigration of cor- 
tical (as well as medullary) thymocytes was observed on day 
5 and, less frequently,  on day 7 of CSA treatment  (data not 
shown). 
Discussion 
Although the emigration of cortical thymocytes to periph- 
eral lymphoid tissues has long been  suggested  (38),  this  is 
to  our  knowledge  the  first  direct  demonstration  of  this 
phenomenon, albeit under unphysiological conditions.  More- 
co 
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Figure 5.  Representative flow 
cytometric  profiles of  (A)  CD4 
and/or  CD8,  and (B) TCR oe/fl 
and/or Thy-1 expression  by RTE in 
normal rats and those treated with 
0.015% CSA for 3 and 5 d. RTE 
were identified by three-color flow 
cytometric analysis of LN cells 16 
h after intrathymic injection with 
FITC.  The  percentage of  total 
FITC +  LN  cells (RTE)  in  each 
window  is indicated. 
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phenomenon in antigen-stimulated rats (Durkin, Seto, and 
I. Goldschneider, unpublished results), and to a lesser extent 
in normal rats (37). Nonetheless, despite the qualitative demon- 
stration of cortical thymocyte emigration by phenotypic anal- 
ysis of intrathymically labeled T cells, some of the quantita- 
tive aspects  of the present study warrant discussion. 
For example, it could be argued that the marked decline 
in cortical thymocytes in '~50% of CSA-treated rats resulted 
primarily from increased cell death  and/or  decreased cell 
proliferation within the thymus, rather than from increased 
cell export from the thymus. Several lines of evidence sug- 
gest that this is not the case. First, there was an inverse corre- 
lation between the size of the thymus and the percentage 
of DP, TCR ~x/13  l~  Thy-1  ~ T cells present in LN and SPL 
of individual CSA-treated animals.  Second, in those rats in 
which CSA caused a marked decrease in total thymocytes, 
DP T cells constituted *30% of total lymphocytes in LN, 
thereby increasing the total number of peripheral T cells by 
an estimated 400  x  106 cells.  This calculation assumes a 
total  of 109  peripheral  T  cells  in  age-,  weight-  and  sex- 
matched control rats, based on the observation that the SPL 
contains ~40% of the total T cells in the body (40).  Third, 
the estimated number of immature T cells that appeared in 
the peripheral lymphoid tissues of CSA-treated rats approxi- 
mated the total number of  cells that were lost from the thymus 
of the same animals by day 5. Fourth, most of these DP T 
cells expressed TdT, which normally is present only in im- 
mature cortical thymocytes (29,  38, 39). Fifth, in previous 
studies we have demonstrated that many of these DP T cells 
express the CS1.21 antigen, which also is specific for a subset 
of cortical thymocytes in normal rats (26). 
These findings are consistent with recent reports from other 
laboratories  of the  appearance  of DP  cells  in  peripheral 
lymphoid tissues of CSA-treated, irradiated and bone marrow- 
reconstituted rats (8, 28). Hence, by as yet undefined mecha- 
nisms, CSA appears to induce the release of cortical thymo- 
cytes at a less mature stage and in much greater numbers than 
those released in normal animals. Moreover, after the surge 
in the release of cortical (and medullary) thymocytes during 
the first week of CSA therapy, thymic emigration ceases (Figs. 
4 and 5), and the number of thymocytes once again increases 
(Fig. 3 B). Kinetic studies of thymocytopoiesis indicate that 
the halt in thymocyte export during CSA treatment is due 
to a block in the differentiation of TdT § to TdT-  cortical 
thymocytes, coupled with exhaustion of the supply of preex- 
isting exportable cells from the cortex and medulla (Hossein 
Zadeh, H., and I. Goldschneider, manuscript in preparation). 
These studies also show that the increase in total thymocytes 
during the second week of CSA treatment is due to "piling 
up" of immature cortical thymocytes  behind this block. Most 
importantly, these studies suggest that the completeness and 
rapidity of onset of the block in cortical thymocyte differen- 
tiation during the first week of CSA treatment are the major 
determinants of the extent of emigration of cortical thymo- 
cytes to the peripheral lymphoid tissues. Thus, it appears that 
in those animals in which the imposition of the block is rapid 
and  complete,  few  TdT +  cortical  thymocytes  leave  the 
thymus, whereas in those animals in which the block ini- 
tially is "leaky" large numbers of cortical thymocytes emigrate. 
Nonetheless, it still is possible  that the variability in the 
appearance of DP T cells in CSA-treated rats, observed here 
and in previous studies (26, 27), is due in part to differences 
in postthymic survival and/or proliferation of RTE in the 
peripheral lymphoid tissues of individual animals. Indeed, we 
have recently demonstrated that a large portion of the SP 
RTE in diabetes-prone, but not diabetes-resistant,  BB/W 
strain rats disappear (apoptosis?) within 24 h of their release 
from the thymus (Hossein Zadeh, H.,  D.  Greiner, and I. 
Goldschneider, manuscript in preparation). However, the in- 
verse correlation between the decrease in thymocytes and the 
increase in RTE after CSA treatment, as well as the arith- 
metic (as opposed to geometric) accumulation of DP T cells 
with time, speaks against massive postthymic death and/or 
selective proliferation of surviving RTE in the present study. 
It is also possible  that CSA influences the appearance of 
phenotypically immature T cells by altering peripheral T cell 
development directly. This does not appear to be true, inas- 
much as  the present  and previous  results  (37)  show  that 
thymectomy selectively causes  a decline in Thy-1 § T  cells 
that is neither prevented nor reversed by subsequent CSA treat- 
ment. Thus,  our experiments demonstrate that,  after per- 
mitting (or inducing) a burst of export of cortical thymo- 
cytes, CSA induces a delayed pharmacological "thymectomy" 
by preventing the continued export of any thymocytes. This 
conclusion is further supported by the report of Beschorner 
et al. (41), who showed that the elevated proportion of DP 
T cells in CSA-treated rats decreases markedly between 7 and 
21  d  after thymectomy and cessation of CSA treatment. 
At first glance, it appears that the modest twofold increase 
in export of RTE in CSA-treated rats observed in Figs.  4 
and 5 is insufficient to account for the marked increase in 
the proportion of DP T  cells observed in Figs.  1 and 3 A. 
Therefore, it should be noted that the former figures record 
the accumulation of RTE over a 16-h period, whereas the 
latter figures record the accumulation over a period of 7 d. 
Thus, as we have previously observed in normal rats, although 
only 3-4% ofLN T cells are replaced by Thy-1 + RTE every 
24 h, m20% of total LN T cells are Thy-1 § , due to the ac- 
cumulation of differentiating RTE over a 7-d interval (37). 
Inasmuch as the 16-h export of RTE in CSA-treated rats ex- 
ceeds that of untreated rats by a mean of 3%  of total LN 
cells (Fig. 4), and inasmuch as most of these extra RTE have 
cortical thymocyte phenotypes (Fig.  5), an accumulation of 
'~4.5% RTE above replacement levels every 24 h could readily 
produce the mean increases in DP LN cells observed in Fig. 
3 A. Indeed, the linear increment ofDP T cells as a function 
of time in Fig. 3 A can itself  be best explained by the progres- 
sive accumulation of RTE after the onset of CSA treatment. 
The extent of the increase in DP T cells in individual animals 
would then depend on the duration of export of DP RTE 
from thymus and their fate in peripheral lymphoid tissues, 
both subjects of ongoing investigation. 
The functional attributes of the novel subset of DP, Thy- 
1  hi, TCR o~/~  l~  TdT + RTE have not been investigated; 
neither has its long-term fate been determined. However, sev- 
290  Migration  of Cortical Thymocytes  in Cyclosporin  A-treated Rats eral lines of evidence suggest that many of the ceils exported 
from the thymus of CSA-treated animals may not have un- 
dergone or completed intrathymic selection. Thus, positive 
and negative selection of the TCK c~/B T cell repertoire has 
been reported to involve DP cells that express intermediate 
levels of TCK (42); and postsdection thymocytes are TCR  hi 
(43).  In contrast,  CSA prevents the maturation  of thymo- 
cytes to the TCPx  hi stage (13, 26). Also, CSA interferes with 
the process of clonal deletion of thymocytes by certain an- 
tigens (16,  20);  and self-reactive T  cells occur in increased 
frequency in the peripheral lymphoid tissues of CSA-treated 
animals  (14). It is possible that these events are causally related 
and are the consequence,  at least in part,  of CSA-induced 
damage to some of the thymic stromal cells that participate 
in intrathymic selection, such as medullary epithelial cells and 
interdigitating  dendritic  cells (20-25). 
Perhaps the strongest evidence against intrathymic selec- 
tion  in CSA-treated  rats is our observation that  the great 
majority of the DP KTE express the enzyme TdT,  which 
has been shown to be responsible for the generation of  junc- 
tional diversity of gene segments in the generation of func- 
tional TCK molecules (44). In unpublished studies, we have 
found that  such TdT §  cortical  thymocytes undergo  rapid 
proliferation,  whereas most of their  TdT-  progeny in the 
thymus cortex undergo apoptosis. This raises the possibility 
that  the survivors of negative selection constitute  a subset 
of TdT-  cortical thymocytes. Furthermore,  the notion that 
many of the cortical thymocytes that are exported from the 
thymus during CSA treatment are self-reactive is consistent 
with reports indicating that the thymus is essential for the 
induction of syngeneic GVHD and organ-specific autoim- 
mune disease during the first 2 wk of CSA therapy, but not 
thereafter  (4,  9). 
Because CSA has been shown to enhance the deletion of 
superantigen-reactive  T cells in the peripheral lymphoid tissues 
(45), presumably by extrathymic mechanisms of T cell reper- 
toire selection (46,  47), it will be important  to determine 
if CSA also affects the postthymic selection of the TCK reper- 
toire to self-antigens.  For if, as we postulate,  some of the 
TdT +  KTE  described  in  the  present  study  undergo  ex- 
trathymic maturation without further selection mechanisms, 
autoaggressive T cells could be generated and, in the absence 
of effective immunoregulation,  permitted  to  function.  If 
confirmed,  this may prove to be one of the mechanisms by 
which GVHD and organ-specific autoimmune  diseases  are 
mediated in CSA-treated animals (3, 9, 43), despite conflicting 
evidence from other laboratories (8, 48). Moreover, since the 
CD45RC-  T  cell subset appears  to play a protective role 
against GVHD in rats (49, 50), and since most CD45KC- 
T  cells in normal rats are KTE and their immediate descen- 
dants (37),  it is possible that  the paucity of CD45RC-  T 
cells in rats treated for >1 wk with CSA (our unpublished 
observations) may further expedite the development of syn- 
geneic  GVHD  and  other  autoreactive  disorders  in  these 
animals. 
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